{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:19:43Z","timestamp":1788373183896,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:00:00Z","timestamp":1788307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Nathan Shock Center, University of Texas Health Science Center at San Antonio","award":["P30 AG013339"],"award-info":[{"award-number":["P30 AG013339"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["GeroScience"],"DOI":"10.1007\/s11357-026-02485-4","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T16:46:28Z","timestamp":1788367588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting cellular senescence mitigates chemotherapy-induced bone loss in young and aged mice"],"prefix":"10.1007","author":[{"given":"David J.","family":"Izquierdo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Blancarte-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Schurman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgit","family":"Schilling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Woloszyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Salmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9625-8078","authenticated-orcid":false,"given":"Vaida","family":"Glatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,2]]},"reference":[{"issue":"1","key":"2485_CR1","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2485_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jgo.2022.10.008","volume":"1","author":"WB Garner","year":"2023","unstructured":"Garner WB, Smith BD, Ludmir EB, Wakefield DV, Shabason J, Williams GR, Martin MY, Wang Y, Ballo MT, VanderWalde NA. Predicting future cancer incidence by age, race, ethnicity, and sex. J Geriatr Oncol. 2023;1: 101393.","journal-title":"J Geriatr Oncol."},{"issue":"4","key":"2485_CR3","volume":"17","author":"E Kourtis","year":"2025","unstructured":"Kourtis E, Zygogiannis K, Fanourgiakis I, Koulalis D, Stathopoulos KD. Understanding and managing fracture risk in patients with cancer: a literature review. Cureus. 2025(4): e83082.","journal-title":"Cureus."},{"issue":"3","key":"2485_CR4","doi-asserted-by":"publisher","DOI":"10.1002\/jbm4.10187","volume":"3","author":"KM Sturgeon","year":"2019","unstructured":"Sturgeon KM, Mathis KM, Rogers CJ, Schmitz KH, Waning DL. Cancer- and chemotherapy-induced musculoskeletal degradation. JBMR Plus. 2019;3(3): e10187.","journal-title":"JBMR Plus."},{"key":"2485_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2024.102828","volume":"130","author":"N Zhu","year":"2024","unstructured":"Zhu N, Ni H, Guo S, Shen YQ, Chen Q. Bone complications of cancer treatment. Cancer Treat Rev. 2024;130:102828.","journal-title":"Cancer Treat Rev"},{"key":"2485_CR6","doi-asserted-by":"crossref","unstructured":"Kciuk M, Gielecinska A, Mujwar S, Kolat D, Kaluzinska-Kolat Z, Celik I, Kontek R. Doxorubicin-an agent with multiple mechanisms of anticancer activity. Cells. 2023;12(4).","DOI":"10.3390\/cells12040659"},{"key":"2485_CR7","doi-asserted-by":"crossref","unstructured":"Park HJ, Yoon SY, Park JN, Suh JH, Choi HS. Doxorubicin induces bone loss by increasing autophagy through a mitochondrial ROS\/TRPML1\/TFEB axis in osteoclasts. Antioxidants (Basel). 2022;11(8).","DOI":"10.3390\/antiox11081476"},{"issue":"10","key":"2485_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0078043","volume":"8","author":"T Rana","year":"2013","unstructured":"Rana T, Chakrabarti A, Freeman M, Biswas S. Doxorubicin-mediated bone loss in breast cancer bone metastases is driven by an interplay between oxidative stress and induction of TGFbeta. PLoS One. 2013;8(10): e78043.","journal-title":"PLoS One."},{"issue":"10","key":"2485_CR9","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1634\/theoncologist.11-10-1121","volume":"11","author":"TA Guise","year":"2006","unstructured":"Guise TA. Bone loss and fracture risk associated with cancer therapy. Oncologist. 2006;11(10):1121\u201331.","journal-title":"Oncologist"},{"issue":"9","key":"2485_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ctrv.2015.09.003","volume":"41","author":"S D\u2019Oronzo","year":"2015","unstructured":"D\u2019Oronzo S, Stucci S, Tucci M, Silvestris F. Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications. Cancer Treat Rev. 2015;41(9):798\u2013808.","journal-title":"Cancer Treat Rev."},{"key":"2485_CR11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ctrv.2018.06.007","volume":"69","author":"S Otto","year":"2018","unstructured":"Otto S, Pautke C, Van den Wyngaert T, Niepel D, Schiodt M. Medication-related osteonecrosis of the jaw: prevention, diagnosis and management in patients with cancer and bone metastases. Cancer Treat Rev. 2018;69:177\u201387.","journal-title":"Cancer Treat Rev."},{"issue":"5","key":"2485_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s11864-021-00835-2","volume":"22","author":"A Diana","year":"2021","unstructured":"Diana A, Carlino F, Giunta EF, Franzese E, Guerrera LP, Di Lauro V, Ciardiello F, Daniele B, Orditura M. Cancer Treatment-Induced Bone Loss (CTIBL): state of the art and proper management in breast cancer patients on endocrine therapy. Curr Treat Options Oncol. 2021;22(5):45.","journal-title":"Curr Treat Options Oncol."},{"issue":"Suppl 1","key":"2485_CR13","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.3747\/co.2008.174","volume":"15","author":"MN Khan","year":"2008","unstructured":"Khan MN, Khan AA. Cancer treatment-related bone loss: a review and synthesis of the literature. Curr Oncol. 2008;15(Suppl 1):S30-40.","journal-title":"Curr Oncol"},{"key":"2485_CR14","first-page":"163","volume":"14","author":"B Dhabhar","year":"2022","unstructured":"Dhabhar B. Cancer treatment-induced bone loss: role of denosumab in non-metastatic breast cancer. Breast Cancer (Dove Med Press). 2022;14:163\u201373.","journal-title":"Breast Cancer (Dove Med Press)."},{"issue":"1","key":"2485_CR15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.15283\/ijsc.2008.1.1.55","volume":"1","author":"MJ Kim","year":"2008","unstructured":"Kim MJ, Kim MH, Kim SA, Chang JS. Age-related deterioration of hematopoietic stem cells. Int J Stem Cells. 2008;1(1):55\u201363.","journal-title":"Int J Stem Cells."},{"issue":"3","key":"2485_CR16","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s007740050081","volume":"17","author":"S Nishida","year":"1999","unstructured":"Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J Bone Miner Metab. 1999;17(3):171\u20137.","journal-title":"J Bone Miner Metab"},{"issue":"12","key":"2485_CR17","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4000","volume":"21","author":"BG Childs","year":"2015","unstructured":"Childs BG, Durik M, Baker DJ, van Deursen JM. Cellular senescence in aging and age-related disease: from mechanisms to therapy. Nat Med. 2015;21(12):1424\u201335.","journal-title":"Nat Med"},{"issue":"3","key":"2485_CR18","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1172\/JCI64098","volume":"123","author":"T Tchkonia","year":"2013","unstructured":"Tchkonia T, Zhu Y, van Deursen J, Campisi J, Kirkland JL. Cellular senescence and the senescent secretory phenotype: therapeutic opportunities. J Clin Invest. 2013;123(3):966\u201372.","journal-title":"J Clin Invest"},{"issue":"7501","key":"2485_CR19","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1038\/nature13193","volume":"509","author":"JM van Deursen","year":"2014","unstructured":"van Deursen JM. The role of senescent cells in ageing. Nature. 2014;509(7501):439\u201346.","journal-title":"Nature"},{"issue":"6","key":"2485_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1083\/jcb.201306073","volume":"203","author":"EC Swanson","year":"2013","unstructured":"Swanson EC, Manning B, Zhang H, Lawrence JB. Higher-order unfolding of satellite heterochromatin is a consistent and early event in cell senescence. J Cell Biol. 2013;203(6):929\u201342.","journal-title":"J Cell Biol"},{"key":"2485_CR21","doi-asserted-by":"crossref","unstructured":"von Zglinicki T, Saretzki G, Ladhoff J, d'Adda di Fagagna F, Jackson SP. Human cell senescence as a DNA damage response. Mech Ageing Dev. 2005;126(1):111\u20137.","DOI":"10.1016\/j.mad.2004.09.034"},{"issue":"1","key":"2485_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/acel.12287","volume":"14","author":"DV Ziegler","year":"2015","unstructured":"Ziegler DV, Wiley CD, Velarde MC. Mitochondrial effectors of cellular senescence: beyond the free radical theory of aging. Aging Cell. 2015;14(1):1\u20137.","journal-title":"Aging Cell"},{"issue":"11","key":"2485_CR23","first-page":"2284","volume":"55","author":"E Wang","year":"1995","unstructured":"Wang E. Senescent human fibroblasts resist programmed cell death, and failure to suppress bcl2 is involved. Cancer Res. 1995;55(11):2284\u201392.","journal-title":"Cancer Res"},{"issue":"8","key":"2485_CR24","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1038\/ncb2784","volume":"15","author":"JC Acosta","year":"2013","unstructured":"Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, Pascual G, Morris KJ, Khan S, Jin H, Dharmalingam G, Snijders AP, Carroll T, Capper D, Pritchard C, Inman GJ, Longerich T, Sansom OJ, Benitah SA, Zender L, Gil J. A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. 2013;15(8):978\u201390.","journal-title":"Nat Cell Biol"},{"key":"2485_CR25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"2485_CR26","doi-asserted-by":"publisher","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6(12):2853\u201368.","journal-title":"PLoS Biol"},{"issue":"9","key":"2485_CR27","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1038\/nm.4385","volume":"23","author":"JN Farr","year":"2017","unstructured":"Farr JN, Xu M, Weivoda MM, Monroe DG, Fraser DG, Onken JL, et al. Targeting cellular senescence prevents age-related bone loss in mice. Nat Med. 2017;23(9):1072\u20139.","journal-title":"Nat Med"},{"key":"2485_CR28","doi-asserted-by":"crossref","unstructured":"Yi JS, Huang Y, Kwaczala AT, Kuo IY, Ehrlich BE, Campbell SG, Giordano FJ, Bennett AM. Low-dose dasatinib rescues cardiac function in Noonan syndrome. JCI Insight. 2016;1(20).","DOI":"10.1172\/jci.insight.90220"},{"key":"2485_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.fitote.2015.09.018","volume":"106","author":"G D\u2019Andrea","year":"2015","unstructured":"D\u2019Andrea G. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia. 2015;106:256\u201371.","journal-title":"Fitoterapia"},{"key":"2485_CR30","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.exger.2014.10.012","volume":"68","author":"JL Kirkland","year":"2015","unstructured":"Kirkland JL, Tchkonia T. Clinical strategies and animal models for developing senolytic agents. Exp Gerontol. 2015;68:19\u201325.","journal-title":"Exp Gerontol"},{"issue":"4","key":"2485_CR31","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/acel.12344","volume":"14","author":"Y Zhu","year":"2015","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, et al. The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell. 2015;14(4):644\u201358.","journal-title":"Aging Cell"},{"issue":"5","key":"2485_CR32","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1158\/0008-5472.CAN-19-2348","volume":"80","author":"Z Yao","year":"2020","unstructured":"Yao Z, Murali B, Ren Q, Luo X, Faget DV, Cole T, et al. Therapy-induced senescence drives bone loss. Cancer Res. 2020;80(5):1171\u201382.","journal-title":"Cancer Res"},{"issue":"10","key":"2485_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0292268","volume":"18","author":"JP Rose","year":"2023","unstructured":"Rose JP, Schurman CA, King CD, Bons J, Patel SK, Burton JB, O\u2019Broin A, Alliston T, Schilling B. Deep coverage and quantification of the bone proteome provides enhanced opportunities for new discoveries in skeletal biology and disease. PLoS One. 2023;18(10): e0292268.","journal-title":"PLoS One."},{"issue":"1","key":"2485_CR34","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41413-023-00303-7","volume":"12","author":"CA Schurman","year":"2024","unstructured":"Schurman CA, Kaya S, Dole N, Luna NMM, Castillo N, Potter R, Rose JP, Bons J, King CD, Burton JB, Schilling B, Melov S, Tang S, Schaible E, Alliston T. Aging impairs the osteocytic regulation of collagen integrity and bone quality. Bone Res. 2024;12(1):13.","journal-title":"Bone Res."},{"issue":"6","key":"2485_CR35","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1021\/pr070056t","volume":"6","author":"X Jiang","year":"2007","unstructured":"Jiang X, Ye M, Jiang X, Liu G, Feng S, Cui L, et al. Method development of efficient protein extraction in bone tissue for proteome analysis. J Proteome Res. 2007;6(6):2287\u201394.","journal-title":"J Proteome Res"},{"issue":"6","key":"2485_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250137","volume":"17","author":"J Rose","year":"2022","unstructured":"Rose J, Basisty N, Zee T, Wehrfritz C, Bose N, Desprez PY, Kapahi P, Stoller M, Schilling B. Comprehensive proteomic quantification of bladder stone progression in a cystinuric mouse model using data-independent acquisitions. PLoS One. 2022;17(6): e0250137.","journal-title":"PLoS One."},{"key":"2485_CR37","doi-asserted-by":"publisher","unstructured":"Creecy A, Brown KL, Rose KL, Voziyan P, Nyman JS. Post-translational modifications in collagen type I of bone in a mouse model of aging. Bone. 2021;143:115763. https:\/\/doi.org\/10.1016\/j.bone.2020.115763.","DOI":"10.1016\/j.bone.2020.115763"},{"issue":"8","key":"2485_CR38","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1002\/pmic.201100463","volume":"12","author":"C Escher","year":"2012","unstructured":"Escher C, Reiter L, MacLean B, Ossola R, Herzog F, Chilton J, et al. Using iRT, a normalized retention time for more targeted measurement of peptides. Proteomics. 2012;12(8):1111\u201321.","journal-title":"Proteomics"},{"key":"2485_CR39","doi-asserted-by":"crossref","unstructured":"Gillet LC, Navarro P, Tate S, Rost H, Selevsek N, Reiter L, Bonner R, Aebersold R. Targeted data extraction of the MS\/MS spectra generated by data-independent acquisition: a new concept for consistent and accurate proteome analysis. Mol Cell Proteomics. 2012;11(6):O111 016717.","DOI":"10.1074\/mcp.O111.016717"},{"issue":"1","key":"2485_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41467-017-00249-5","volume":"8","author":"BC Collins","year":"2017","unstructured":"Collins BC, Hunter CL, Liu Y, Schilling B, Rosenberger G, Bader SL, Chan DW, Gibson BW, Gingras AC, Held JM, Hirayama-Kurogi M, Hou G, Krisp C, Larsen B, Lin L, Liu S, Molloy MP, Moritz RL, Ohtsuki S, Schlapbach R, Selevsek N, Thomas SN, Tzeng SC, Zhang H, Aebersold R. Multi-laboratory assessment of reproducibility, qualitative and quantitative performance of SWATH-mass spectrometry. Nat Commun. 2017;8(1):291.","journal-title":"Nat Commun."},{"issue":"1","key":"2485_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1021\/acs.jproteome.7b00170","volume":"17","author":"T Burger","year":"2018","unstructured":"Burger T. Gentle introduction to the statistical foundations of false discovery rate in quantitative proteomics. J Proteome Res. 2018;17(1):12\u201322.","journal-title":"J Proteome Res"},{"issue":"3","key":"2485_CR42","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey JD. A direct approach to false discovery rates. J R Stat Soc Ser B Stat Methodol. 2002;64(3):479\u201398.","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"issue":"6","key":"2485_CR43","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1038\/nm.4324","volume":"23","author":"OH Jeon","year":"2017","unstructured":"Jeon OH, Kim C, Laberge RM, Demaria M, Rathod S, Vasserot AP, et al. Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment. Nat Med. 2017;23(6):775\u201381.","journal-title":"Nat Med"},{"key":"2485_CR44","doi-asserted-by":"crossref","unstructured":"Ryu S, Sidorov S, Ravussin E, Artyomov M, Iwasaki A, Wang A, Dixit VD. The matricellular protein SPARC induces inflammatory interferon-response in macrophages during aging. Immunity. 2022;55(9):1609\u201326 e7.","DOI":"10.1016\/j.immuni.2022.07.007"},{"issue":"28","key":"2485_CR45","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202523511","volume":"13","author":"CA Schurman","year":"2026","unstructured":"Schurman CA, Kaur G, Kaya S, Bons J, Aguirre CG, Liu Q, King CD, Wilson KA, Baker HL, Hady M, Luna NM, Bieri G, Villeda SA, Ellerby LM, Schilling B, Alliston T. Alzheimer\u2019s disease risk factor APOE4 exerts dimorphic effects on female bone. Adv Sci (Weinh). 2026;13(28): e23511.","journal-title":"Adv Sci (Weinh)."},{"issue":"6","key":"2485_CR46","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1002\/jbmr.3978","volume":"35","author":"A Chandra","year":"2020","unstructured":"Chandra A, Lagnado AB, Farr JN, Monroe DG, Park S, Hachfeld C, Tchkonia T, Kirkland JL, Khosla S, Passos JF, Pignolo RJ. Targeted reduction of senescent cell burden alleviates focal radiotherapy-related bone loss. J Bone Miner Res. 2020;35(6):1119\u201331.","journal-title":"J Bone Miner Res"},{"issue":"1","key":"2485_CR47","doi-asserted-by":"publisher","first-page":"17279","DOI":"10.1038\/s41598-025-01717-5","volume":"15","author":"MM Ali","year":"2025","unstructured":"Ali MM, Simmons P, Warren A, Gatrell LB, Resende-Coelho A, McElroy T, Allen AR, Almeida M. The adverse effects of chemotherapy on bone mass are not prevented by senolytics. Sci Rep. 2025;15(1):17279.","journal-title":"Sci Rep."},{"issue":"7","key":"2485_CR48","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1172\/JCI42285","volume":"120","author":"MB Greenblatt","year":"2010","unstructured":"Greenblatt MB, Shim JH, Zou W, Sitara D, Schweitzer M, Hu D, et al. The p38 MAPK pathway is essential for skeletogenesis and bone homeostasis in mice. J Clin Invest. 2010;120(7):2457\u201373.","journal-title":"J Clin Invest"},{"key":"2485_CR49","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/bonekey.2015.80","volume":"4","author":"C Thouverey","year":"2015","unstructured":"Thouverey C, Caverzasio J. Focus on the p38 MAPK signaling pathway in bone development and maintenance. Bonekey Rep. 2015;4:711.","journal-title":"Bonekey Rep"},{"issue":"6","key":"2485_CR50","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ctrv.2012.02.008","volume":"38","author":"P Hadji","year":"2012","unstructured":"Hadji P, Gnant M, Body JJ, Bundred NJ, Brufsky A, Coleman RE, et al. Cancer treatment-induced bone loss in premenopausal women: a need for therapeutic intervention? Cancer Treat Rev. 2012;38(6):798\u2013806.","journal-title":"Cancer Treat Rev"},{"issue":"11","key":"2485_CR51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","volume":"23","author":"S Khosla","year":"2012","unstructured":"Khosla S, Oursler MJ, Monroe DG. Estrogen and the skeleton. Trends Endocrinol Metab. 2012;23(11):576\u201381.","journal-title":"Trends Endocrinol Metab"},{"issue":"10","key":"2485_CR52","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16(10):626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"2485_CR53","doi-asserted-by":"publisher","first-page":"502","DOI":"10.3389\/fimmu.2016.00502","volume":"7","author":"LV Kovtonyuk","year":"2016","unstructured":"Kovtonyuk LV, Fritsch K, Feng X, Manz MG, Takizawa H. Inflamm-aging of hematopoiesis, hematopoietic stem cells, and the bone marrow microenvironment. Front Immunol. 2016;7:502.","journal-title":"Front Immunol"},{"issue":"9","key":"2485_CR54","first-page":"5640","volume":"12","author":"L Zhou","year":"2020","unstructured":"Zhou L, Kuai F, Shi Q, Yang H. Doxorubicin restrains osteogenesis and promotes osteoclastogenesis in vitro. Am J Transl Res. 2020;12(9):5640\u201354.","journal-title":"Am J Transl Res"},{"key":"2485_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.mad.2022.111689","volume":"206","author":"E Bientinesi","year":"2022","unstructured":"Bientinesi E, Lulli M, Becatti M, Ristori S, Margheri F, Monti D. Doxorubicin-induced senescence in normal fibroblasts promotes in vitro tumour cell growth and invasiveness: The role of Quercetin in modulating these processes. Mech Ageing Dev. 2022;206: 111689.","journal-title":"Mech Ageing Dev"},{"issue":"10","key":"2485_CR56","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1161\/HYPERTENSIONAHA.125.25408","volume":"82","author":"R Venkatasubramanian","year":"2025","unstructured":"Venkatasubramanian R, Darrah MA, Mahoney SA, Hutton DA, Maurer GS, Ludwig KR, Van Dongen NS, Greenberg NT, Longtine AG, Brunt VE, Singh P, Galligan JJ, Trujillo MN, Kapahi P, Melov S, Rossman MJ, Seals DR, Clayton ZS. Cellular senescence mediates doxorubicin chemotherapy-induced aortic stiffening: role of glycation stress. Hypertension. 2025;82(10):1767\u201377.","journal-title":"Hypertension"},{"issue":"1","key":"2485_CR57","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3000599","volume":"18","author":"N Basisty","year":"2020","unstructured":"Basisty N, Kale A, Jeon OH, Kuehnemann C, Payne T, Rao C, Holtz A, Shah S, Sharma V, Ferrucci L, Campisi J, Schilling B. A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. 2020;18(1): e3000599.","journal-title":"PLoS Biol."},{"issue":"1","key":"2485_CR58","doi-asserted-by":"publisher","first-page":"4827","DOI":"10.1038\/s41467-022-32552-1","volume":"13","author":"D Saul","year":"2022","unstructured":"Saul D, Kosinsky RL, Atkinson EJ, Doolittle ML, Zhang X, LeBrasseur NK, Pignolo RJ, Robbins PD, Niedernhofer LJ, Ikeno Y, Jurk D, Passos JF, Hickson LJ, Xue A, Monroe DG, Tchkonia T, Kirkland JL, Farr JN, Khosla S. A new gene set identifies senescent cells and predicts senescence-associated pathways across tissues. Nat Commun. 2022;13(1):4827.","journal-title":"Nat Commun."},{"issue":"7","key":"2485_CR59","doi-asserted-by":"publisher","DOI":"10.1111\/acel.13832","volume":"22","author":"C Ahire","year":"2023","unstructured":"Ahire C, Nyul-Toth A, DelFavero J, Gulej R, Faakye JA, Tarantini S, Kiss T, Kuan-Celarier A, Balasubramanian P, Ungvari A, Tarantini A, Nagaraja R, Yan F, Tang Q, Mukli P, Csipo T, Yabluchanskiy A, Campisi J, Ungvari Z, Csiszar A. Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain. Aging Cell. 2023;22(7): e13832.","journal-title":"Aging Cell."},{"key":"2485_CR60","doi-asserted-by":"publisher","DOI":"10.1556\/1661.2026.00111","author":"D Nagy","year":"2026","unstructured":"Nagy D, Chandragiri SS, Kordestan KV, Ekambaram S, Nagykaldi M, Patai R, et al. Chemotherapy-induced chemobrain and cognitive decline: a pharmacological perspective on neurovascular injury as a therapeutic target. Adv Transl Res. 2026. https:\/\/doi.org\/10.1556\/1661.2026.00111.","journal-title":"Adv Transl Res"}],"container-title":["GeroScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11357-026-02485-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11357-026-02485-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T18:02:49Z","timestamp":1788372169000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11357-026-02485-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,2]]},"references-count":60,"alternative-id":["2485"],"URL":"https:\/\/doi.org\/10.1007\/s11357-026-02485-4","relation":{},"ISSN":["2509-2723"],"issn-type":[{"value":"2509-2723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,2]]},"assertion":[{"value":"2 June 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}